 | |
| Clinical data | |
|---|---|
| Trade names | Notandron-Depot |
| Other names | Methandriol dioxononanoate; Methylandrostenediol dioxononanoate; Methandriol bisoxononanoate; Methylandrostenediol bisoxononanoate; 17α-Methylandrost-5-ene-3,17β-diol 3,17β-di(3-oxononanoate) |
| Routes of administration | Intramuscular injection |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C38H60O6 |
| Molar mass | 612.892 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Methandriol bisenanthoyl acetate (brand nameNotandron-Depot), ormethylandrostenediol bisenanthoyl acetate, also known as17α-methylandrost-5-ene-3β,17β-diol 3β,17β-di(3-oxononanoate), is asynthetic,injectedanabolic–androgenic steroid (AAS) and a17α-alkylatedderivative of5-androstenediol.[1][2] It is anandrogen ester—specifically, the C3β,17β di(3-oxononanoate) (or dienanthoylacetate)ester ofmethandriol (17α-methyl-5-androstenediol)—and acts as aprodrug of methandriol in the body.[1] Methandriol bisenanthoyl acetate is administered byintramuscular injection and, relative to methandriol, has an extended duration via this route due to adepot effect afforded by itsester.[citation needed]
 | Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |
